Recap: Phathom Pharmaceuticals Q2 Earnings

  Phathom Pharmaceuticals (NASDAQ:PHAT) reported its Q2 earnings results on Tuesday, August 2, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

 

Phathom Pharmaceuticals (NASDAQ:PHAT) reported its Q2 earnings results on Tuesday, August 2, 2022 at 08:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Phathom Pharmaceuticals missed estimated earnings by 29.13%, reporting an EPS of $-1.33 versus an estimate of $-1.03.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.1 which was followed by a 1.95% increase in the share price the next day.

 

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Phathom Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Wynn Resorts Stock Ticks Higher On Q4 Performance – Here’s Why

Wynn Resorts reported quarterly earnings of $1.91 per share which beat the analyst consensus estimate of $1.15 per share by just over 66%. The company reported quarterly sales of $1.84 billion, beating the analyst consensus estimate of $1.74 billion by 5.83% and representing a 83.08% increase over sales of $1 billion from the same period last year.

WYNN